Expertise in
3
conditions

Takashi Yokoi

Nishinomiya-hama, JP 
Expertise in
3
conditions
Nishinomiya-hama, JP 

Overview

Takashi Yokoi practices practicing medicine in Nishinomiya-hama, Japan.

Mr. Yokoi is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

He is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Nishinomiya-hama, Japan
Other Locations
Japan
Hirakata, Japan
Osaka, Japan
Moriguchi, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3

49 Total Publications

Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
Journal: JAMA network open
Published: February 24, 2023

Frequently Asked Questions about Takashi Yokoi

Is Takashi Yokoi a top-rated expert for Mesothelioma?

MediFind is an objective health platform that identifies experts based on real-world data. Takashi Yokoi is classified as an Advanced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Takashi Yokoi participate in research or clinical trials?

Yes. Takashi Yokoi has published 49 articles and abstracts on conditions like Mesothelioma. You can view a list of Takashi Yokoi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yokoi's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile